🇺🇸 Montelukast (High FeNO group) in United States

Montelukast (High FeNO group) (Montelukast (High FeNO group)) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Montelukast (High FeNO group) in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Respiratory approved in United States

Frequently asked questions

Is Montelukast (High FeNO group) approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Montelukast (High FeNO group) in United States?

Hull University Teaching Hospitals NHS Trust is the originator. The local marketing authorisation holder may differ — check the official source linked above.